News
June 15, 2022 / News
Vipergen and LEO Pharma Partner for DNA Encoded Library (DEL)-Based Drug Discovery for Dermatology Indications
COPENHAGEN, Denmark, June 15, 2022—Vipergen, a leading provider of small-molecule drug discovery services based on DNA-encoded library (DEL) technologies, announced today a multi-target drug discovery partnership with LEO Pharma focused…
Read More
April 4, 2022 / News
Vipergen Establishes DNA Encoded Library (DEL)-Based Drug Discovery Partnership with Theseus Pharmaceuticals Focused on Targeted Cancer Therapies
COPENHAGEN, Denmark, April 4, 2022 — Vipergen, a leading provider of small-molecule drug discovery services based on DNA-encoded library (DEL) technologies, announced today the signing of a drug discovery agreement…
Read More
December 21, 2021 / News
Vipergen Establishes Research Partnership with Bayer to Discover Novel Compounds for Pharmaceuticals and More Sustainable Crop Protection Solutions
COPENHAGEN, Denmark, December 21, 2021 – Vipergen, a leading provider of small-molecule drug discovery services based on DNA-encoded library (DEL) technologies, announced today the signing of a multi-target research agreement…
Read More
November 23, 2021 / News
Vipergen Establishes Research Partnership with Aligos Therapeutics Focused on DNA Encoded Library (DEL)-Based Drug Discovery for Viral Infections and Liver Diseases
COPENHAGEN, Denmark, November 23, 2021—Vipergen, a leading provider of small-molecule drug discovery services based on DNA-encoded library (DEL) technologies, announced today the signing of a multi-target drug discovery agreement with…
Read More
November 15, 2021 / News
Vipergen Establishes Research Partnership with ALK Focused on DNA-Encoded Library (DEL)-Based Drug Discovery for Allergy Immunotherapies
COPENHAGEN, Denmark, November 15, 2021—Vipergen, a leading provider of small-molecule drug discovery services based on DNA-encoded library (DEL) technologies, announced today the signing of a multi-target drug discovery agreement with…
Read More
October 21, 2021 / News
BASF and Vipergen accelerate targeted research and development of sustainable crop protection products
Limburgerhof, Germany, and Copenhagen, Denmark, October 21, 2021 – Farmers worldwide are facing the challenge of feeding a growing population while reducing the impact of agriculture on the environment. BASF…
Read More
September 14, 2021 / News
Vipergen Establishes Research Partnership with PhoreMost Focused on DNA Encoded Library (DEL)-Based Drug Discovery
COPENHAGEN, Denmark, September 14, 2021—Vipergen, a leading provider of small-molecule drug discovery services based on DNA-encoded library (DEL) technologies, announced today the signing of a multi-target drug discovery agreement with…
Read More
May 17, 2021 / News
Vipergen Establishes Partnership with Anavo Therapeutics to Support Phosphatase-Targeted Discovery Programs
COPENHAGEN, Denmark, May 17, 2021—Vipergen, a leading provider of small-molecule drug discovery services based on DNA-encoded library (DEL) technologies, announced today the signing of a drug discovery service agreement with…
Read More
March 17, 2021 / News
Vipergen strengthens leadership by appointing Dr Leif Kongskov Larsen as Director of Biology and promoting Dr Allan Beck Christensen to Director of Screening Technologies
COPENHAGEN, Denmark, March 17, 2021— Vipergen ApS today announced the appointment of Leif Kongskov Larsen, Ph.D. as Director of Biology, and the promotion of Allan Beck Christensen, Ph.D., to Director…
Read More
February 17, 2021 / News
Vipergen Publishes First Technology for Screening DNA-Encoded Small-Molecule Libraries (DELs) Inside Living Cells
Vipergen Publishes First Technology for ScreeningDNA-Encoded Small-Molecule Libraries (DELs) Inside Living Cells— Vipergen’s Cellular Binder Trap Enrichment® (cBTE) technology provides a robust systemto accelerate and improve drug discovery — —…
Read More
December 1, 2020 / News
Casma Therapeutics and Vipergen Enter Into Drug Discovery Agreement
CAMBRIDGE, Mass. and COPENHAGEN, Denmark, December 1, 2020—Casma Therapeutics, Inc. and Vipergen ApS announced today the signing of a drug discovery agreement. Under the terms of the agreement, Vipergen will…
Read More
November 6, 2020 / News
Commercial release of the first technology for DEL screening inside a living cell
Copenhagen, Denmark, November 6th, 2020 – – Vipergen ApS announced today the commercial release of the first technology for screening of DNA-encoded small molecule libraries (DELs) inside a living cell….
Read More